Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Payables: 2023-2025

Historic Payables for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $585,000.

  • Camp4 Therapeutics' Payables fell 84.90% to $585,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 16.12% up from last year.
  • As of Q3 2025, Camp4 Therapeutics' Payables stood at $585,000, which was down 51.05% from $1.2 million recorded in Q2 2025.
  • Camp4 Therapeutics' Payables' 5-year high stood at $3.9 million during Q3 2024, with a 5-year trough of $585,000 in Q3 2025.
  • For the 3-year period, Camp4 Therapeutics' Payables averaged around $1.6 million, with its median value being $1.2 million (2024).
  • As far as peak fluctuations go, Camp4 Therapeutics' Payables climbed by 16.12% in 2024, and later slumped by 84.90% in 2025.
  • Camp4 Therapeutics' Payables (Quarterly) stood at $1.0 million in 2023, then climbed by 16.12% to $1.2 million in 2024, then slumped by 84.90% to $585,000 in 2025.
  • Its Payables was $585,000 in Q3 2025, compared to $1.2 million in Q2 2025 and $1.4 million in Q1 2025.